Literature DB >> 22264583

Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey.

Oya Halicioglu1, Sezin A Akman, Bengu Tatar, Ruya Atesli, Sukran Kose.   

Abstract

The age-specific prevalence of hepatitis A virus (HAV) infection and risk factors were evaluated in a low socioeconomic population in Izmir. Children and adolescents 1-18 years of age admitted to the outpatient clinics for follow-up visits, or healthy children between April-December 2009 were investigated for anti-HAV antibodies by a cross-sectional study. A questionnaire on sociodemographic and hygiene information was obtained from the parents. All unvaccinated children against HAV were grouped according to their age. Seven hundred and twenty-nine children were enrolled in the study. Total HAV IgG seropositivity was 29.5% while age related values were as follows: 1-2 years, 21.4%; 2.1-5 years, 15.1%; 5.1-8 years, 20.1%; 8.1-11 years, 32.6%; 11.1-14 years, 44.3% and 14.1-18 years, 52.4%. The presence of anti-HAV IgG was associated significantly with low family income and lack of education of parents and living in a crowded family. HAV infection was endemic in a population of children living in Izmir. Anti-HAV vaccination should be considered for preschool children because teenagers are at risk of infection in this region. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264583     DOI: 10.1016/j.tmaid.2012.01.001

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  5 in total

1.  Seroprevalence of hepatitis a and associated factors among 1-15 year old children in Eastern Turkey.

Authors:  Serap Karaman; Kamuran Karaman; Baran Serdar Kızılyıldız; Nesrin Ceylan; Sultan Kaba; Mehmet Parlak; Burhan Beger; Abdullah Ceylan
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Shifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination.

Authors:  Burcin Nalbantoglu; Metin M Donma; Burcu Ozdilek; Erkut Karasu; Aysin Nalbantoglu
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

3.  Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study.

Authors:  Nasser Mostafavi; Roya Kelishadi; Elham Kazemi; Behrooz Ataei; Majid Yaran; Mohammad Esmaeil Motlagh; Mostafa Qorbani; Ramin Heshmat; Mohamad Hasan Tajadini; Shervin Ghaffari Hoseini
Journal:  Hepat Mon       Date:  2016-08-17       Impact factor: 0.660

Review 4.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

5.  Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey.

Authors:  Necla Tulek; Metin Ozsoy; Cigdem Moroglu; Meliha Cagla Sonmezer; Fatih Temocin; Gunay Tuncer Ertem; Fatma Sebnem Erdinc
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.